114.31
0.11%
-0.13
시간 외 거래:
114.31
Stifel Financial Corp 주식(SF)의 최신 뉴스
Brad Edgar Joins Stifel as Managing Director and Lead Healthcare Equity Trader - The Manila Times
ESAB (NYSE:ESAB) Downgraded by Stifel Nicolaus to Hold - MarketBeat
Parker-Hannifin (NYSE:PH) Rating Lowered to "Hold" at Stifel Nicolaus - MarketBeat
Stifel Strengthens Healthcare Trading with Key Hire: Brad Edgar Joins as Managing Director | SF Stock News - StockTitan
Crane downgraded to Hold from Buy at Stifel - TipRanks
Have Insiders Sold Stifel Financial Shares Recently? - Simply Wall St
Curi RMB Capital LLC Grows Stock Holdings in Stifel Financial Corp. (NYSE:SF) - MarketBeat
Oppenheimer Asset Management Inc. Sells 45,884 Shares of Stifel Financial Corp. (NYSE:SF) - MarketBeat
Insider Sale: COO David Sliney Sells 25,000 Shares of Stifel Fin - GuruFocus.com
Stifel starts Snam SpA stock with Buy rating, sees upside potential - Investing.com
Stifel financial COO David Sliney sells $2.9 million in stock - Investing.com
Zions Bancorporation N.A. Has $2.54 Million Holdings in Stifel Financial Corp. (NYSE:SF) - MarketBeat
Stifel Nicolaus Cuts Northwest Natural (NYSE:NWN) Price Target to $44.00 - MarketBeat
Stifel Nicolaus Forecasts Strong Price Appreciation for Dutch Bros (NYSE:BROS) Stock - MarketBeat
Vistagen to Present at the Stifel 2024 Healthcare Conference - Yahoo Finance
Ligand to Present at Stifel 2024 Healthcare Conference - Yahoo Finance
Stifel bullish on Equity Residential stock, citing valuation upside and FFO growth - Investing.com
Equillium to Present at the Stifel Healthcare Conference - Yahoo Finance
Capital Research Global Investors Bolsters Stake in Stifel Finan - GuruFocus.com
Oculis to Present at the Stifel 2024 Healthcare Conference - Yahoo Finance
Stifel Raises Coherent Corp. (COHR) Price Target to $120, Maintains Buy Rating After Strong Q1 Results and Positive Q2 Outlook - Insider Monkey
Stifel maintains Buy on Apogee Therapeutics with $95 target - Investing.com
FMR LLC Bolsters Stake in Stifel Financial Corp - GuruFocus.com
Stifel raises Viridian Therapeutics target to $41, keeps buy rating - Investing.com
Stifel loses another big arbitration lawsuit involving star Miami broker - InvestmentNews
On Holding stock earns Buy rating from Stifel, driven by top-line beat and gross margin gains - Investing.com
Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference - Yahoo Finance
QurAlis to Participate at the Stifel 2024 Healthcare Conference - Yahoo Finance
Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor Conferences - Yahoo Finance
Stifel cuts Lucid Group target to $3.50, maintains hold - Investing.com
Stifel cuts Rivian target to $16, maintains buy rating - Investing.com
Home Depot (NYSE:HD) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat
Stifel Nicolaus Forecasts Strong Price Appreciation for Xponential Fitness (NYSE:XPOF) Stock - MarketBeat
Geron to Present at Stifel 2024 Healthcare ConferenceKey Management Insights Coming | GERN Stock News - StockTitan
Stifel Nicolaus Lowers Baxter International (NYSE:BAX) Price Target to $38.00 - MarketBeat
Geron to Participate in the Stifel 2024 Healthcare Conference - Yahoo Finance
Diamond Hill Capital Management Inc. Has $32.17 Million Stock Position in Stifel Financial Corp. (NYSE:SF) - MarketBeat
Los Angeles Capital Management LLC Purchases 8,481 Shares of Stifel Financial Corp. (NYSE:SF) - MarketBeat
Principal Financial Group Inc. Has $94.52 Million Stock Position in Stifel Financial Corp. (NYSE:SF) - MarketBeat
Amalgamated Bank Reduces Stake in Stifel Financial Corp. (NYSE:SF) - MarketBeat
Stifel raises Hanesbrands target to $8, maintains hold rating - Investing.com
Stifel Financial Corp. (NYSE:SF) Holdings Reduced by Fiera Capital Corp - MarketBeat
Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference - Yahoo Finance
AppLovin price target raised to $250 from $185 at Stifel - Yahoo Finance
Radnor Capital Management LLC Makes New $447,000 Investment in Stifel Financial Corp. (NYSE:SF) - MarketBeat
Van ECK Associates Corp Grows Position in Stifel Financial Corp. (NYSE:SF) - MarketBeat
Rep. Josh Gottheimer Sells Off Shares of Stifel Financial Corp. (NYSE:SF) - MarketBeat
Stifel cuts STAAR Surgical stock target, maintains buy amid China concerns - Investing.com
Intellia Therapeutics maintains $54 shares target and Buy rating with Stifel - Investing.com
Stifel Financial stock soars to all-time high of $108.67 By Investing.com - Investing.com Australia
Stifel rejects CFTC’s WhatsApp settlement offer - Banking Dive
Stifel reaffirms steady stock target on Hershey despite Q3 earnings miss - Investing.com
KBW Earns Multiple No. 1 Spots in Influential Rankings - GlobeNewswire
NervGen Pharma to Present at the Stifel 2024 Healthcare Conference - Yahoo Finance
Decoding Stifel Financial Corp (SF): A Strategic SWOT Insight - GuruFocus.com
Stifel raises Aclaris Therapeutics target to $3 on program focus - Investing.com
Stifel Balks At CFTC Offer To Settle Text Messaging Case - Law360
Stifel Financial stock soars to all-time high of $108.67 - Investing.com
Pliant Therapeutics to Participate in the Stifel Healthcare Conference - Yahoo Finance
Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference - The Manila Times
Portillo’s stock faces pressure as traffic declines and value strategy questioned—Stifel - Investing.com
Stifel cuts NXP Semiconductors target to $231 from $260 - Investing.com
OnKure to Present at the Stifel 2024 Healthcare Conference - Yahoo Finance
Stifel maintains $69 target on Beam Therapeutics stock - Investing.com
Armada Hoffler Properties (NYSE:AHH) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat
자본화:
|
볼륨(24시간):